Open AccessAutologous serum therapy in chronic urticaria: A promising complement to antihistamines
Author(s) -
Panchami Debbarman,
Abheek Sil,
Piyush Kanti Datta,
Debabrata Bandyopadhyay,
Nilay Kanti Das
Publication year - 2014
Publication title -
indian journal of dermatology/indian journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.395
H-Index - 36
eISSN - 1998-3611
pISSN - 0019-5154
DOI - 10.4103/0019-5154.135490
Subject(s) - medicine , dermatology life quality index , cetirizine , placebo , group b , adverse effect , antihistamine , chronic urticaria , randomized controlled trial , group a , pill , gastroenterology , anesthesia , pharmacology , alternative medicine , disease , pathology
Chronic urticaria (CU) is a vexing problem and patients of CU suffer from the morbidity that arise from irritable itch and weals and are also subjected to a huge antihistamine pill burden. The symptoms are more in autoreactive urticaria (AU) where auto-antibodies in blood flares-up the condition. Search for newer effective modalities which can reduce pill burden is a felt need.